ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

TRIPSSubscribe to TRIPS

TRIPS Agreement and Amendment of Patents Act in India

This article examines whether the amendment to the Indian Patents Act, 1970 has taken advantage of the provisions available under the TRIPS agreement, and look at the exemption, exception and compulsory licensing provisions in pharmaceuticals.

Small-Scale Units in the Era of Globalisation

This paper focuses on the ongoing changes in the business environment and the analysis of their implications for small-scale units. Specifically, it looks at possible ways of improving the competitive strength and commercial viability of small-scale units in the changing context. For this, substantial improvements will be needed in technology, such as mechanisation, organisation and information and the revamping of policy measures to encourage the growth of small units through collective efforts, ending their isolated mode of operation.

Transnational Corporate Science and Regulation of Agricultural Biotechnology

Interpreted as a dialectical process the biotech controversy is seen to be developing incrementally in directions that none of its participants can necessarily be said to have intended. The 'final' shape and content of the regulatory settlement is likely to be the outcome of an explicit or implicit social compromise and cannot yet be predicted. This paper suggests that the regulatory regime already in place in India is only an initial attempt to impose a narrow, elite framing of the issues reflecting the interests of powerful economic forces.

Patents for Biotechnology Inventions in TRIPs

While the Trade-Related Aspects of Intellectual Property Rights Agreement of the Uruguay Round has been controversial, Article 27 (3) (b) of this agreement is more so. It pertains to patenting of biotechnology inventions. The origin of this article may be traced to conventions in European countries, and also discuss the biotechnology patenting question under the 1970 Patent Act in India.

Policy Implications of India's Patent Reforms

Recent changes in India's patent policy indicate a paradigm shift in seeking greater protection of intellectual property rights. On one hand, this has given rise to fears being expressed over the impending collapse of local firms; on the other, there is optimism amidst expectation of a large increase in patent activity of domestic actors. This paper analyses the impact of the policy shift, examines the ability of domestic players to adjust to a new patent regime and suggests guidelines to ensure the policy's accessibility to a majority of players.

People's Movement against Global Capitalism

In the post-cold war world, issues of equality and social justice still remain vital concerns. As the increasing gap between rich and poor countries, and the growing desperation of the poor and the unemployed reveal, market economy is not an all-encompassing panacea and it thus becomes necessary to find an alternative. It is here that civil society and the local community must have the space to act and where necessary even solicit the state's intervention - a moving idea behind those protest movements seen earlier this year. The challenge of the new century is to bring these ideas together in a new consistent design, towards a "mobilisation against globalisation" through which a more humane and equitable economic and social order will possibly take shape.

India at Doha: Retrospect and Prospect

In developing our future negotiating positions, we need to think far more systematically than we have done so far. At least three strategic conclusions can be drawn from the Uruguay Round and Doha experiences. First, we need to consider the direct benefits to us of any demand we put forward in the negotiations. Second, diplomacy requires that we define our negotiating position positively rather than negatively. Finally, and most importantly, prior to defining our negotiating position, we must think hard about the end-game. By repeatedly staking a position that is far from what we eventually accept, as has been the case in the UR Agreement and the Doha Declaration, we lose credibility in future negotiations and risk being isolated. This risk has now increased manifold with the entry of China into WTO.

Legal Factors in TRIPS

To ensure that patent-abusive situations, such as the ones that occurred in South Africa, do not repeat themselves, member countries of the WTO must draft balanced domestic patent legislations based on a rational interpretation of the TRIPS text.

What Happened at Doha?

India has been singularly successful in achieving its objectives in Doha - in securing primacy for implementation problems, in bringing the anti-dumping agreement to the negotiating table, in getting a waiver from the agreement on TRIPS in times of public health emergencies and creating the opportunity for protection of geographical indications and traditional knowledge, in ensuring exemption for integrated textile products from anti-dumping action and the negotiation of textile tariff peaks, in keeping core labour standards out of the purview of WTO and in postponing negotiations on the four Singapore issues. The only area where it had to compromise to some extent was in respect of trade and environment.

TRIPS, Product Patents and Pharmaceuticals

Participants in the international debate on patents and pharmaceuticals have begun exploring two distinct sets of TRIPScompliant options/mechanisms that would enable patients in the developing world to access new treatments at affordable costs. The first set relates primarily to 'global' ailments, where R and D is already supported by the north, and includes options such as compulsory licensing, 'tiered' pricing and national drug price regulations. The second set of mechanisms is aimed at 'creating markets' for treatments relating to poor country-specific ailments in a manner that allows affordability without endangering incentives to future research and innovation.

Pages

Back to Top